Inhibikase Therapeutics, Inc. (IKT)
NASDAQ: IKT · Real-Time Price · USD
1.670
-0.040 (-2.34%)
Sep 5, 2025, 4:00 PM - Market closed

Inhibikase Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
16
Market Cap
124.44M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024---
Dec 31, 2023260.50K137.06K111.03%
Dec 31, 2022123.44K-2.98M-96.02%
Dec 31, 20213.10M2.40M343.92%
Dec 31, 2020698.47K-424.27K-37.79%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.